Brandt, O. et al. (2024) ‘Pemphigus foliaceus successfully treated with upadacitinib’, Journal of the European Academy of Dermatology and Venereology [Preprint]. Available at: https://doi.org/10.1111/jdv.20225.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44. Available at: https://doi.org/10.1007/s10875-024-01667-z.

Borrego-Yaniz, Gonzalo et al. (2024) ‘Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study’, The Lancet Rheumatology, 6, pp. e374–e383. Available at: https://doi.org/10.1016/S2665-9913(24)00064-X.

Baldrich, A. et al. (2023) ‘Post-transplant inflammatory bowel disease associated with donor-derived TIM-3 deficiency’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3282819/v1.

Buergin, Natacha et al. (2023) ‘Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination’, European Journal of Heart Failure, 25, pp. 1871–1881. Available at: https://doi.org/10.1002/ejhf.2978.

Donners, Ricardo et al. (2023) ‘Chronic stage magnetic resonance imaging findings in patients with shoulder injury related to vaccine administration (SIRVA)’, Skeletal Radiology, 52, pp. 1695–1701. Available at: https://doi.org/10.1007/s00256-023-04334-3.

Hemmig, Andrea K. et al. (2023) ‘A diagnostic performance study of the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis in a cohort of patients presenting with suspected giant cell arteritis’, Arthritis and Rheumatology, 75, pp. 1075–1077. Available at: https://doi.org/10.1002/art.42440.

Hemmig, Andrea Katharina et al. (2023) ‘Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study’, RMD open, 9. Available at: https://doi.org/10.1136/rmdopen-2022-002866.

Hemmig, Andrea K. et al. (2023) ‘Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [¹⁸F]FDG Positron Emission Tomography or Ultrasound’, Diagnostics, 13. Available at: https://doi.org/10.3390/diagnostics13233559.

Hirsiger, Julia R. et al. (2023) ‘Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1087502.

Iudici, Michele et al. (2023) ‘Management of giant-cell arteritis in Switzerland: an online national survey’, Swiss Medical Weekly, 153. Available at: https://doi.org/10.57187/smw.2023.40051.

Jauch, Annaïse J. et al. (2023) ‘Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency’, Journal of Allergy and Clinical Immunology, 152, pp. 500–516. Available at: https://doi.org/10.1016/j.jaci.2023.03.022.

Lopez-Morales, Joanan et al. (2023) ‘Multiplexed on-yeast serological assay for immune escape screening of SARS-CoV-2 variants’, iScience, 26. Available at: https://doi.org/10.1016/j.isci.2023.106648.

Mensch, Noemi et al. (2023) ‘Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study’, RMD Open, 9. Available at: https://doi.org/10.1136/rmdopen-2023-003301.

Menter, Thomas et al. (2023) ‘Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1285168.

Seitz, Luca et al. (2023) ‘Cluster analysis of flowcytometric immunophenotyping with extended T cell subsets in suspected immunodeficiency’, Immunity, Inflammation and Disease, 11. Available at: https://doi.org/10.1002/iid3.1106.

Valore, Luca et al. (2023) ‘Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine’, Frontiers in Cardiovascular Medicine, 10, p. 1135848. Available at: https://doi.org/10.3389/fcvm.2023.1135848.

Roth MS et al. (2022) ‘Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose’, Journal of the European Academy of Dermatology and Venereology, 36(11), pp. e880–e883. Available at: https://doi.org/10.1111/jdv.18387.

Hirsiger JR et al. (2022) ‘Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.’, The journal of allergy and clinical immunology. In practice, 10(9), pp. 2452–2455.e3. Available at: https://doi.org/10.1016/j.jaip.2022.06.020.

Hemmig AK et al. (2022) ‘Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.’, Seminars in arthritis and rheumatism, 55, p. 152017. Available at: https://doi.org/10.1016/j.semarthrit.2022.152017.

Hirsiger JR et al. (2022) ‘Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.’, 20(4). Available at: https://doi.org/10.1111/jth.15665.

Imfeld S et al. (2022) ‘A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis.’, Diagnostics (Basel, Switzerland), 12(3). Available at: https://doi.org/10.3390/diagnostics12030728.

Raptis CE et al. (2022) ‘Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.’, Frontiers in immunology, 13, p. 1016927. Available at: https://doi.org/10.3389/fimmu.2022.1016927.

Bongers LD et al. (2021) ‘Complications and cost estimations in herpes zoster - a retrospective analysis at a Swiss tertiary dermatology clinic.’, Swiss medical weekly, 151, p. w30081. Available at: https://doi.org/10.4414/smw.2021.w30081.

Battegay R et al. (2021) ‘Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.’, Swiss medical weekly, 151, p. w30084. Available at: https://doi.org/10.4414/smw.2021.w30084.

Guedel DS et al. (2021) ‘Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study.’, Swiss medical weekly, 151, p. w30090. Available at: https://doi.org/10.4414/smw.2021.w30090.

Haaf P et al. (2021) ‘The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.’, Swiss medical weekly, 151, p. w30087. Available at: https://doi.org/10.4414/smw.2021.w30087.

Cittone MG et al. (2021) ‘The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.’, 19(9). Available at: https://doi.org/10.1111/jth.15421.

Baenziger-Sieber P et al. (2021) ‘Throat swelling following tocilizumab infusion-not always angioedema.’, Rheumatology advances in practice, 5(3), p. rkab072. Available at: https://doi.org/10.1093/rap/rkab072.

Güdel DS and Berger CT (2021) ‘[Update and practical advice for travel vaccinations and consultations in primary care].’, Therapeutische Umschau. Revue therapeutique, 78(2), pp. 83–92. Available at: https://doi.org/10.1024/0040-5930/a001242.

Hirsiger, J. R. et al. (2021) ‘Anaphylaxis to goat’s and sheep’s milk in an adult tolerant to cow milk: A sensitization profile study’, Journal of Investigational Allergology & Clinical Immunology, 32(2), pp. 154–156. Available at: https://doi.org/10.18176/jiaci.0721.

Hirsiger, Julia R. et al. (2021) ‘Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination’, Journal of Autoimmunity, 124. Available at: https://doi.org/10.1016/j.jaut.2021.102714.

Légeret C et al. (2021) ‘JAK Inhibition in a Patient with X-Linked Reticulate Pigmentary Disorder.’, 41(1). Available at: https://doi.org/10.1007/s10875-020-00867-7.

Rottenburger, Christof et al. (2021) ‘¹⁸F-FDG PET/CT compared with ultrasound and biopsy for detection of vasculitis of the temporal artery branches’, Swiss Medical Weekly, 151. Available at: https://doi.org/10.4414/smw.2021.20512.

Sazgary L et al. (2021) ‘The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization.’, European journal of case reports in internal medicine, 8(7), p. 002617. Available at: https://doi.org/10.12890/2021_002617.

Meier MA and Berger CT (2020) ‘A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study.’, BMC infectious diseases, 20(1), p. 891. Available at: https://doi.org/10.1186/s12879-020-05634-y.

Berger CT and Daikeler T (2020) ‘Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: “Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone” by Samson and Bonnotte.’, Annals of the rheumatic diseases, 79(8), p. e103. Available at: https://doi.org/10.1136/annrheumdis-2019-215729.

Imfeld S et al. (2020) ‘[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?’, Rheumatology (Oxford, England), 59(4), pp. 772–778. Available at: https://doi.org/10.1093/rheumatology/kez362.

Deigendesch, Nikolaus et al. (2020) ‘Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling’, Rheumatology, 59(11), pp. e102–e104. Available at: https://doi.org/10.1093/rheumatology/keaa301.

Fuchs, Philipp S. et al. (2020) ‘Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients’, Frontiers in Immunology, 11(11), p. 613130. Available at: https://doi.org/10.3389/fimmu.2020.613130.

Sarcevic J et al. (2020) ‘Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism.’, 11. Available at: https://doi.org/10.3389/fimmu.2020.01435.

Hirsiger JR et al. (2019) ‘Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation.’, Open forum infectious diseases, 6(9), p. ofz317. Available at: https://doi.org/10.1093/ofid/ofz317.

Ankli B et al. (2019) ‘The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.’, Swiss medical weekly, 149, p. w20121. Available at: https://doi.org/10.4414/smw.2019.20121.

Berger CT et al. (2019) ‘Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.’, 78(7). Available at: https://doi.org/10.1136/annrheumdis-2018-214704.

Aschwanden M et al. (2019) ‘Vessel wall plasticity in large vessel giant cell arteritis: An ultrasound follow-up study’, Rheumatology (United Kingdom), 58(5), pp. 792–797. Available at: https://doi.org/10.1093/rheumatology/key383.

Bühler T et al. (2019) ‘Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination.’, 4. Available at: https://doi.org/10.1038/s41541-019-0152-2.

Berger CT et al. (2018) ‘The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis.’, Swiss medical weekly, 148, p. w14661. Available at: https://doi.org/10.4414/smw.2018.14661.

Fuchs, P.S. et al. (2018) ‘AB0653 Prediction of relapses in autoimmune large-vessel vasculitis – towards personalised immunosuppressive treatment stewardship’. BMJ Publishing Group Ltd and European League Against Rheumatism. Available at: https://doi.org/10.1136/annrheumdis-2018-eular.5474.

Schegk, E. et al. (2018) ‘FRI0517 Vessel wall morphology in giant cell arteritis– a longterm sonographic follow-up study’. BMJ Publishing Group Ltd and European League Against Rheumatism. Available at: https://doi.org/10.1136/annrheumdis-2018-eular.5478.

Ankli B et al. (2018) ‘Calcium pyrophosphate deposition disease: a frequent finding in patients with long-standing erosive gout.’, Scandinavian journal of rheumatology. 16.08.2017, 47(2), pp. 127–130. Available at: https://doi.org/10.1080/03009742.2017.1332239.

Bigler MB et al. (2018) ‘Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al.’, 70(2). Available at: https://doi.org/10.1002/art.40363.

Berger, Christoph T., Recher, Mike and Daikeler, Thomas (2018) ‘Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis’, Rheumatology (Oxford, England), 57(1), pp. 196–197. Available at: https://doi.org/10.1093/rheumatology/kex336.

Frick C et al. (2018) ‘Nano-scale microfluidics to study 3D chemotaxis at the single cell level.’, PloS one. 07.06.2018, 13(6), p. e0198330. Available at: https://doi.org/10.1371/journal.pone.0198330.

Miho E et al. (2018) ‘Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires.’, Frontiers in immunology, 9, p. 224. Available at: https://doi.org/10.3389/fimmu.2018.00224.

Recher, Mike et al. (2018) Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination., p. 17. Available at: https://doi.org/10.1038/s41541-018-0059-3.

Yu WH et al. (2018) ‘ADCC-Mediated CD56(DIM) NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection.’, Pathogens & immunity, 3(1), pp. 2–18. Available at: https://doi.org/10.20411/pai.v3i1.228.

Bischof, Antje et al. (2017) ‘Serum neurofilament light chain: a biomarker of neuronal injury in vasculitic neuropathy’, Annals of the rheumatic diseases, 77(7), pp. 1093–1094. Available at: https://doi.org/10.1136/annrheumdis-2017-212045.

Budweg, Joris et al. (2017) ‘Factors associated with significant MRI findings in medical walk-in patients with acute headache’, Swiss medical weekly, 146, p. w14349.

Carmona, F. David et al. (2017) ‘A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis’, American journal of human genetics, 100(1), pp. 64–74. Available at: https://doi.org/10.1016/j.ajhg.2016.11.013.

Elkuch, M. et al. (2017) ‘Low immunoglobulin E flags two distinct types of immune dysregulation’, Clinical & Experimental Immunology, 187(3), pp. 345–352. Available at: https://doi.org/10.1111/cei.12885.

Imfeld, Stefan et al. (2017) ‘[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic’, Eur Heart J Cardiovasc Imaging, 19(8), pp. 933–940. Available at: https://doi.org/10.1093/ehjci/jex259.

Kistner, Anne et al. (2017) ‘Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis’, Rheumatology, 56(5), pp. 829–834. Available at: https://doi.org/10.1093/rheumatology/kew469.

Marquardsen, Florian A. et al. (2017) ‘Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency’, Journal of clinical immunology, 37(7), pp. 707–714. Available at: https://doi.org/10.1007/s10875-017-0431-5.

Navarini, Alexander A. et al. (2017) ‘Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis’, Journal Of Allergy And Clinical Immunology, 139(3), pp. 1043–1046.e5. Available at: https://doi.org/10.1016/j.jaci.2016.08.042.

Nordmann, Thierry M. et al. (2017) ‘Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations’, Blood, 129(7), pp. 879–882. Available at: https://doi.org/10.1182/blood-2016-09-740217.

Berger, Christoph T. and Hess, Christoph (2016) ‘Neglected for too long? - CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells’, The Journal for Clinical Investigation, 126(5), pp. 1646–8. Available at: https://doi.org/10.1172/jci87429.

Budweg, Joris et al. (2016) ‘Factors associated with significant MRI findings in medical walk-in patients with acute headache’, Swiss medical weekly, 146, p. w14349. Available at: https://doi.org/10.4414/smw.2016.14349.

Recher, Mike et al. (2016) ‘A “Too Negative” ANA Test Predicts Antibody Deficiency’, Journal of Clinical Immunology, 36(4), pp. 374–376. Available at: https://doi.org/10.1007/s10875-016-0262-9.

Sips, Magdalena et al. (2016) ‘HLA-C levels impact natural killer cell subset distribution and function’, Human Immunology, 77(12), pp. 1147–1153. Available at: https://doi.org/10.1016/j.humimm.2016.08.004.

Aschwanden M et al. (2015) ‘The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.’, Clinical and experimental rheumatology. 26.05.2015, 33(2 Suppl 89), pp. S–113–5.

Berger CT et al. (2015) ‘Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study.’, Clinical and experimental rheumatology. 26.05.2015, 33(2 Suppl 89), pp. S–122–5.

Berger, Christoph T. et al. (2015) ‘Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection’, Human Vaccines & Immunotherapeutics, 11(2), pp. 391–6. Available at: https://doi.org/10.1080/21645515.2015.1008930.

Berger, Christoph T. et al. (2015) ‘Immune Screening Identifies Novel T Cell Targets Encoded by Antisense Reading Frames of HIV-1’, Journal of Virology, 89(7), pp. 4015–9. Available at: https://doi.org/10.1128/jvi.03435-14.

Berger, C. T. et al. (2015) ‘Diagnosis at your fingertips: splinters and microemboli - is it SLE?’, Lupus, 24(3), pp. 341–2. Available at: https://doi.org/10.1177/0961203314558862.

Bigler, Marc B. et al. (2015) ‘Stress-induced in vivo recruitment of human cytotoxic natural killer cells favors subsets with distinct receptor profiles and associates with increased epinephrine levels’, PLoS ONE, 10(12), p. e0145635. Available at: https://doi.org/10.1371/journal.pone.0145635.

Thoens C et al. (2014) ‘KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.’, Journal of hepatology. 26.04.2014, 61(3), pp. 475–81. Available at: https://doi.org/10.1016/j.jhep.2014.04.020.

Kroy DC et al. (2014) ‘Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.’, Gastroenterology. 19.10.2013, 146(2), pp. 550–61. Available at: https://doi.org/10.1053/j.gastro.2013.10.022.

Balmer ML and Berger CT (2014) ‘[Better vaccinations - new approaches for targeted immunomodulation in healthy and immunosuppressed].’, Therapeutische Umschau. Revue therapeutique, 71(1), pp. 5–15. Available at: https://doi.org/10.1024/0040-5930/a000476.

Cosgrove, Cormac et al. (2014) ‘Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver’, PLoS ONE, 9(8), p. e105950. Available at: https://doi.org/10.1371/journal.pone.0105950.

Haering, Moritz et al. (2014) ‘Incidence and prognostic implications of diplopia in patients with giant cell arteritis’, The Journal of rheumatology, 41(7), pp. 1562–4. Available at: https://doi.org/10.3899/jrheum.130983.

Recher, Mike et al. (2014) ‘Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype’, Journal Of Allergy And Clinical Immunology, 133(5), pp. 1462–5, 1465.e1–5. Available at: https://doi.org/10.1016/j.jaci.2013.10.052.

Kroy, D. et al. (2013) ‘Inhibitory receptor expression and phenotype of virus-specific T cells are linked to tissue localization and HCV control’, Zeitschrift für Gastroenterologie, 51(01). Available at: https://doi.org/10.1055/s-0032-1332147.

Berger CT and Kim AY (2012) ‘IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.’, Infectious disease clinics of North America, 26(4), pp. 863–77. Available at: https://doi.org/10.1016/j.idc.2012.08.010.

Xia Z et al. (2012) ‘A 17q12 allele is associated with altered NK cell subsets and function.’, Journal of immunology (Baltimore, Md. : 1950). 15.02.2012, 188(7), pp. 3315–22. Available at: https://doi.org/10.4049/jimmunol.1102775.

Mothe B et al. (2012) ‘CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.’, PloS one. 04.01.2012, 7(1), p. e29717. Available at: https://doi.org/10.1371/journal.pone.0029717.

Sips, M. et al. (2012) ‘Altered distribution of mucosal NK cells during HIV infection’, Mucosal Immunology, 5(1), pp. 30–40. Available at: https://doi.org/10.1038/mi.2011.40.

Yamanaka, Yvonne J. et al. (2012) ‘Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells’, Integrative Biology, 4(10), pp. 1175–84. Available at: https://doi.org/10.1039/c2ib20167d.

Mothe B et al. (2011) ‘Definition of the viral targets of protective HIV-1-specific T cell responses.’, Journal of translational medicine. 07.12.2011, 9, p. 208. Available at: https://doi.org/10.1186/1479-5876-9-208.

Berger CT and Alter G (2011) ‘Natural killer cells in spontaneous control of HIV infection.’, Current opinion in HIV and AIDS, 6(3), pp. 208–13. Available at: https://doi.org/10.1097/coh.0b013e3283457798.

Ackerman ME et al. (2011) ‘A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.’, Journal of immunological methods. 27.12.2010, 366(1-2), pp. 8–19. Available at: https://doi.org/10.1016/j.jim.2010.12.016.

Berger, Christoph T. et al. (2011) ‘High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control’, Journal of virology, 85(18), pp. 9334–45. Available at: https://doi.org/10.1128/jvi.00460-11.

Dugast, Anne-Sophie et al. (2011) ‘Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals’, Virology, 415(2), pp. 160–7. Available at: https://doi.org/10.1016/j.virol.2011.03.012.

Berger, Christoph T. et al. (2010) ‘Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences’, Journal of Experimental Medicine, 207(1), pp. 61–75. Available at: https://doi.org/10.1084/jem.20091808.

Fink, Nadine Stephanie et al. (2010) ‘Maternal laboratory stress influences fetal neurobehavior : cortisol does not provide all answers’, The journal of maternal fetal & neonatal medicine, 23(6), pp. 488–500. Available at: https://doi.org/10.3109/14767050903300985.

Berger CT et al. (2009) ‘A patient’s wish: anakinra in pregnancy.’, Annals of the rheumatic diseases, 68(11), pp. 1794–5. Available at: https://doi.org/10.1136/ard.2008.105833.

Berger, C T et al. (2009) ‘High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition’, Rheumatology : official journal of the British Society for Rheumatology, 48(3), pp. 258–61. Available at: https://doi.org/10.1093/rheumatology/ken480.

Eriksson, U. (2009) ‘Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy’, Circulation research : journal of the American Heart Association, 105(9), pp. 912–20. Available at: https://doi.org/10.1161/circresaha.109.199802.

Holbro, Andreas et al. (2009) ‘Lymphocyte counts in patients with ANCA-associated vasculitis’, Rheumatology international : clinical and experimental investigations, 29(7), pp. 807–10. Available at: https://doi.org/10.1007/s00296-008-0762-x.

Gasser, Olivier et al. (2008) ‘Testing the ‘cytokine-ome’ theory : a longitudinal pilot study in renal transplant recipients’, Transplantation, 85(3), pp. 491–2. Available at: https://doi.org/10.1097/tp.0b013e318160eeb6.